Progesterone Versus Progesterone Plus Dydrogesterone in FET

Launched by MỸ ĐỨC HOSPITAL · Jun 24, 2019

Keywords

ClinConnect Summary

All patients undergoing FET will receive oral estradiol valerate (Valiera®; Laboratories Recalcine) 8 mg/day from the second or third day of menses for 6 days. Endometrial thickness will be monitored from day six onwards. From day 8-9 of menses, the estradiol dose could be adjusted from 8mg/day to 16mg/day according the development of the endometrium. Progesterone will be started when endometrial thickness reached 8 mm or more. In the first four months, all the patients will be treated with micronized progesterone. In five months later, the intervention will be changed to micronized progest...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Undergoing frozen embryo transfer
• • Endometrial prepared by exogenous hormonal regimen
• • Permanent resident in Vietnam
• Exclusion Criteria:
• • Having \> 2 embryo transfer attempts
• • Having embryo(s) from donors cycles
• • Having embryo(s) from IVM
• • Having embryo(s) from PGT/PGS
• • Having endometrial abnormalities: polyp, sub-mucosal fibroid, cesarean scar defects, endometrial hyperplasia, endometrial fluid accumulation, endometrial adhesion.
• • Participating in another IVF study at the same time